Clinical trials
Phase 3 Atrial Fibrillation trials in the Philippines
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 2 |
| 2016 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 2 |
| Bristol-Myers Squibb | 2 |
| Sanofi | 2 |
| Anthos Therapeutics, Inc. | 1 |
| Daiichi Sankyo | 1 |
| Janssen Research & Development, LLC | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| Population Health Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atrial Fibrillation | 11 |
| Stroke | 5 |
| Atrial Flutter | 2 |
| Embolism | 2 |
| Arrhythmias, Cardiac | 1 |
| Rheumatic Heart Disease | 1 |
| Thrombosis | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.